BMA Stock Analysis: Buy, Sell, or Hold?
BMA - Banco Macro S.A.
$94.01
-3.28 (-3.37%)
▼
5d:
-5.95%
30d:
+20.01%
90d:
+33.66%
HOLD
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: May 27, 2026
0d
Get Alerted When BMA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BMA trades at premium valuation expecting 18.3% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: BMA trades at premium valuation expecting 18.3% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$588459.16
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$365386.84
100.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BMA is currently trading at $94.00, which is considered slightly high relative to its 30-day fair value range of $77.64 to $96.63. At these levels, the market is pricing in 18.3% annual earnings growth.
Technical Outlook: Technically, BMA is showing sideways momentum. Immediate support is located at $84.45, while resistance sits at $103.61. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: BMA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $113.74 (+16.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BMA is showing sideways momentum. Immediate support is located at $84.45, while resistance sits at $103.61. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: BMA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $113.74 (+16.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$77.64 -
$96.63
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.4%)
- BULLISH: Trading below Wall St target ($113.74)
- BULLISH: Expecting earnings turnaround to 18.3% growth with -99.6% revenue growth
- CAUTION: Recommendation downgraded due to -5.9% 5-day decline
Trading Range Analysis
30-Day Trading Range
$77.64 -
$96.63
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$84.45
Resistance Level
$103.61
Current Trend
Sideways
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
0.01
Wall Street Target
$113.74
(+16.9%)
Revenue Growth (YoY)
-99.6%
Earnings Growth (YoY)
-27.4%
Profit Margin
7.6%
Valuation Premium vs History
+18.3% premium
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+18.3%
(market-implied from PE analysis)
1-Year Target
$115.08
(+18%)
2-Year Target
$136.14
(+40%)
3-Year Target
$161.06
(+66%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 62.8%)
$1110637.09
(+1141591%)
Base:
(SPY PE: 0.0, Growth: 62.8%)
$328.32
(+238%)
Bear:
(PE: 0.0, Growth: 62.8%)
$279.07
(+187%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (0x PE) as earnings recover.
Trailing PE: 25.23 | Current EPS (TTM): $4.03
Bull Case
$223.70
(+130%)
Analyst growth 100.0%, PE expands to 27.8
Base Case
$203.36
(+109%)
Market implied 100.0%, PE stable at 25.2
Bear Case
$69.14
(-29%)
Severe decline -20.0%, PE contracts to 21.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 23, 2026 3:30 PM ET
Data refreshes hourly during market hours. Next update: 4:30 PM
Data refreshes hourly during market hours. Next update: 4:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BMA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Banks - Regional Stocks
Top-rated stocks in Banks - Regional by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
USB
U.S. Bancorp |
BUY
24 analysts |
$64 | 65 BUY |
|
CFG
Citizens Financial Group… |
STRONG BUY
17 analysts |
$73 | 64 BUY |
|
PNC
PNC Financial Services G… |
BUY
23 analysts |
$256 | 62 BUY |
|
MTB
M&T Bank Corporation |
BUY
21 analysts |
$233 | 64 BUY |
|
PB
Prosperity Bancshares Inc |
BUY
14 analysts |
$78 | 67 BUY |
